Form 8-K - Current report:
SEC Accession No. 0001193125-25-137497
Filing Date
2025-06-09
Accepted
2025-06-09 09:02:20
Documents
12
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d57209d8k.htm   iXBRL 8-K 31209
  Complete submission text file 0001193125-25-137497.txt   145431

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20250605.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20250605_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20250605_pre.xml EX-101.PRE 11256
14 EXTRACTED XBRL INSTANCE DOCUMENT d57209d8k_htm.xml XML 3648
Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 251032946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)